Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy.
Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H; ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group.
Part Fibre Toxicol. 2005 Oct 6;2:8.PMID: 16209704 [PubMed]Related articlesFree article